Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: Clinical, radiologic, and pathologic characteristics

Mycopathologia

Volumn 159, Issue 2, 2005, Pages 181-188

  Shaukat, Aasma ^a   Bakri, Faris ^a   Young, Paul ^a   Hahn, Theresa ^a,b   Ball, Donna ^b   Baer, Maria R ^a,b   Wetzler, Meir ^a,b   Slack, James L ^a,b   Loud, Peter ^a,b   Czuczman, Myron ^a,b   McCarthy, Philip L ^a,b   Walsh, Thomas J ^c   Segal, Brahm H ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Aspergillus; Filamentous fungal infection; Histology; Transplantation

Indexed keywords

ASPERGILLUS;

ANTIFUNGAL AGENT; CORTICOSTEROID; OKT 3;

ALLOTRANSPLANTATION; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CYTOCHEMISTRY; FEMALE; GRAFT VERSUS HOST REACTION; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; NEUTROPENIA; PATHOLOGY; RADIOGRAPHY; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; SURVIVAL;

ADRENAL CORTEX HORMONES; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; FEMALE; GRAFT VS HOST DISEASE; HISTOCYTOCHEMISTRY; HUMANS; MALE; MIDDLE AGED; MUROMONAB-CD3; NEUTROPENIA; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 20944444356     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-004-5495-0     Document Type: Review

References (21)

1. SL Gerson GH Talbot S Hurwitz BL Strom EJ Lusk PA. Cassileth 1984 Prolonged granulocytopenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia Ann Intern Med 100 345 351
2. S Ascioglu JH Rex B de Pauw 2002 Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus Clin Infect Dis 34 7 14
3. J Berenguer MC Allende JW Lee 1995 Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone- induced immunosuppression Am J Respir Crit Care Med. 152 1079 1086
4. D Caillot O Casasnovas A Bernard 1997 Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery J Clin Oncol 15 139 147
5. J Maertens J Van Eldere J Verhaegen E Verbeken J Verschakelen M Boogaerts 2002 Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients J Infect Dis 186 1297 1306
6. J Maertens J Verhaegen K Lagrou J Van Eldere M Boogaerts 2001 Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: A prospective validation Blood 97 1604 1610
7. Odabasi Z, Mattiuzzi G, Estey E et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39: 199-205. Epub 2004 Jun 28.
8. AS Pham JJ Tarrand GS May MS Lee DP Kontoyiannis XY Han 2003 Diagnosis of invasive mold infection by real-time quantitative PCR Am J Clin Pathol 119 38 44
9. A Wald W Leisenring JA van Burik RA Bowden 1997 Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation [see comments] J Infect Dis 175 1459 1466
10. JW Baddley TP Stroud D Salzman PG Pappas 2001 Invasive mold infections in allogeneic bone marrow transplant recipients Clin Infect Dis 32 1319 1324
11. WB Grow JS Moreb D Roque 2002 Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital Bone Marrow Transplant 29 15 19
12. E Jantunen P Ruutu L Niskanen 1997 Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients Bone Marrow Transplant 19 801 808
13. PH McWhinney CC Kibbler MD Hamon 1993 Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13Years experience Clin Infect Dis 17 397 404
14. KY Yuen PC Woo MS Ip 1997 Stage-specific manifestation of mold infections in bone marrow transplant recipients: Risk factors and clinical significance of positive concentrated smears Clin Infect Dis 25 37 42
15. KA Marr RA Carter M Boeckh P Martin L Corey 2002 Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors Blood 100 4358 4366
16. T Fukuda M Boeckh RA Carter 2003 Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning Blood 102 827 833
17. TF Patterson WR Kirkpatrick M White 2000 Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group Medicine (Baltimore) 79 250 260
18. DW Denning 1996 Therapeutic outcome in invasive aspergillosis Clin Infect Dis 23 608 615
19. JR Wingard P Kubilis L Lee 1999 Clinical Significance of Nephrotoxicity in Patients Treated with Amphotericin B for Suspected or Proven Aspergillosis Clin Infect Dis 29 1402 1407
20. R Herbrecht DW Denning TF Patterson 2002 Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis New Engl J Med 347 408 415
21. DA Stevens 1998 Combination immunotherapy and antifungal chemotherapy Clin Infect Dis 26 1266 1269